Rank | Gene Set | Z-score |
---|---|---|
1 | drug transmembrane transport (GO:0006855) | 9.27782027 |
2 | urate metabolic process (GO:0046415) | 9.16129577 |
3 | drug transport (GO:0015893) | 8.04449089 |
4 | lysine catabolic process (GO:0006554) | 7.81112861 |
5 | lysine metabolic process (GO:0006553) | 7.81112861 |
6 | drug catabolic process (GO:0042737) | 7.20602988 |
7 | regulation of guanylate cyclase activity (GO:0031282) | 7.00366827 |
8 | epoxygenase P450 pathway (GO:0019373) | 6.93980003 |
9 | organic cation transport (GO:0015695) | 6.85826509 |
10 | aminoglycoside antibiotic metabolic process (GO:0030647) | 6.80013544 |
11 | phosphate ion transport (GO:0006817) | 6.65650923 |
12 | modified amino acid transport (GO:0072337) | 6.35788590 |
13 | * lipoprotein transport (GO:0042953) | 6.06242894 |
14 | fat-soluble vitamin biosynthetic process (GO:0042362) | 6.01247950 |
15 | phosphate ion transmembrane transport (GO:0035435) | 5.91520698 |
16 | renal absorption (GO:0070293) | 5.87349082 |
17 | regulation of triglyceride catabolic process (GO:0010896) | 5.80858897 |
18 | excretion (GO:0007588) | 5.79990435 |
19 | quaternary ammonium group transport (GO:0015697) | 5.70557326 |
20 | positive regulation of guanylate cyclase activity (GO:0031284) | 5.63582985 |
21 | angiotensin maturation (GO:0002003) | 5.38489506 |
22 | cysteine metabolic process (GO:0006534) | 5.37953428 |
23 | endocrine process (GO:0050886) | 5.35657959 |
24 | regulation of systemic arterial blood pressure by hormone (GO:0001990) | 5.35657959 |
25 | regulation of systemic arterial blood pressure mediated by a chemical signal (GO:0003044) | 5.35657959 |
26 | * vitamin D metabolic process (GO:0042359) | 5.30530808 |
27 | aspartate family amino acid catabolic process (GO:0009068) | 5.30412739 |
28 | very-low-density lipoprotein particle assembly (GO:0034379) | 5.30297168 |
29 | phospholipid efflux (GO:0033700) | 5.15379201 |
30 | exogenous drug catabolic process (GO:0042738) | 5.10843600 |
31 | intestinal absorption (GO:0050892) | 5.08862364 |
32 | cellular glucuronidation (GO:0052695) | 5.02346735 |
33 | uronic acid metabolic process (GO:0006063) | 4.96613540 |
34 | glucuronate metabolic process (GO:0019585) | 4.96613540 |
35 | peptide catabolic process (GO:0043171) | 4.90052141 |
36 | flavonoid metabolic process (GO:0009812) | 4.86220056 |
37 | trivalent inorganic anion homeostasis (GO:0072506) | 4.85798919 |
38 | phosphate ion homeostasis (GO:0055062) | 4.85798919 |
39 | glyoxylate metabolic process (GO:0046487) | 4.84256139 |
40 | regulation of cholesterol esterification (GO:0010872) | 4.81689993 |
41 | nonribosomal peptide biosynthetic process (GO:0019184) | 4.75879333 |
42 | sulfur compound transport (GO:0072348) | 4.66924085 |
43 | regulation of systemic arterial blood pressure (GO:0003073) | 4.64572694 |
44 | homocysteine metabolic process (GO:0050667) | 4.63153951 |
45 | high-density lipoprotein particle remodeling (GO:0034375) | 4.62585096 |
46 | tricarboxylic acid metabolic process (GO:0072350) | 4.62086367 |
47 | response to mercury ion (GO:0046689) | 4.58978132 |
48 | carnitine transport (GO:0015879) | 4.55928629 |
49 | amino-acid betaine transport (GO:0015838) | 4.55928629 |
50 | peptide hormone processing (GO:0016486) | 4.42134100 |
51 | toxin transport (GO:1901998) | 4.41496185 |
52 | glutathione biosynthetic process (GO:0006750) | 4.41228642 |
53 | * vitamin transport (GO:0051180) | 4.40129269 |
54 | intestinal cholesterol absorption (GO:0030299) | 4.37665272 |
55 | serine family amino acid metabolic process (GO:0009069) | 4.37380304 |
56 | digestion (GO:0007586) | 4.37247206 |
57 | diacylglycerol metabolic process (GO:0046339) | 4.33857577 |
58 | adhesion of symbiont to host cell (GO:0044650) | 4.33362008 |
59 | virion attachment to host cell (GO:0019062) | 4.33362008 |
60 | regulation of cGMP biosynthetic process (GO:0030826) | 4.32789738 |
61 | short-chain fatty acid metabolic process (GO:0046459) | 4.31930056 |
62 | regulation of bile acid biosynthetic process (GO:0070857) | 4.27197914 |
63 | bile acid and bile salt transport (GO:0015721) | 4.19018167 |
64 | serine family amino acid catabolic process (GO:0009071) | 4.17032721 |
65 | cellular response to nitric oxide (GO:0071732) | 4.13720087 |
66 | oligosaccharide catabolic process (GO:0009313) | 4.12337598 |
67 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.10917607 |
68 | serine family amino acid biosynthetic process (GO:0009070) | 4.00153344 |
69 | renal system process involved in regulation of blood volume (GO:0001977) | 3.99442021 |
70 | reverse cholesterol transport (GO:0043691) | 3.98875897 |
71 | receptor guanylyl cyclase signaling pathway (GO:0007168) | 3.98820069 |
72 | amino-acid betaine metabolic process (GO:0006577) | 3.97968643 |
73 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 3.97504236 |
74 | response to phenylpropanoid (GO:0080184) | 3.94308120 |
75 | polyol transport (GO:0015791) | 3.93501788 |
76 | alkaloid metabolic process (GO:0009820) | 3.91489500 |
77 | drinking behavior (GO:0042756) | 3.91302104 |
78 | actin filament depolymerization (GO:0030042) | 3.86861495 |
79 | metanephric nephron tubule development (GO:0072234) | 3.86713961 |
80 | metanephric tubule development (GO:0072170) | 3.86713961 |
81 | 2-oxoglutarate metabolic process (GO:0006103) | 3.86529751 |
82 | cellular modified amino acid catabolic process (GO:0042219) | 3.81925742 |
83 | vitamin transmembrane transport (GO:0035461) | 3.78687874 |
84 | fructose metabolic process (GO:0006000) | 3.77244636 |
85 | cGMP biosynthetic process (GO:0006182) | 3.66170688 |
86 | bile acid metabolic process (GO:0008206) | 3.63587534 |
87 | peptide biosynthetic process (GO:0043043) | 3.63401460 |
88 | regulation of cholesterol homeostasis (GO:2000188) | 3.61686054 |
89 | regulation of cGMP metabolic process (GO:0030823) | 3.60751823 |
90 | cellular response to reactive nitrogen species (GO:1902170) | 3.57416249 |
91 | cholesterol efflux (GO:0033344) | 3.56535950 |
92 | adhesion of symbiont to host (GO:0044406) | 3.56290616 |
93 | vitamin A metabolic process (GO:0006776) | 3.52846918 |
94 | metanephric nephron epithelium development (GO:0072243) | 3.52158764 |
95 | glutamate metabolic process (GO:0006536) | 3.51642401 |
96 | carnitine metabolic process (GO:0009437) | 3.51352196 |
97 | proline metabolic process (GO:0006560) | 3.51293551 |
98 | fatty acid beta-oxidation (GO:0006635) | 3.50757428 |
99 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.47348497 |
100 | glomerulus development (GO:0032835) | 3.42049047 |
101 | acetyl-CoA metabolic process (GO:0006084) | 3.41967108 |
102 | glucose 6-phosphate metabolic process (GO:0051156) | 3.40106826 |
103 | * lipoprotein metabolic process (GO:0042157) | 3.39394879 |
104 | regulation of cellular extravasation (GO:0002691) | 3.38401810 |
105 | indole-containing compound catabolic process (GO:0042436) | 3.36281952 |
106 | indolalkylamine catabolic process (GO:0046218) | 3.36281952 |
107 | tryptophan catabolic process (GO:0006569) | 3.36281952 |
108 | valine metabolic process (GO:0006573) | 3.35166786 |
109 | transepithelial transport (GO:0070633) | 3.34767299 |
110 | plasma lipoprotein particle remodeling (GO:0034369) | 3.34350168 |
111 | protein-lipid complex remodeling (GO:0034368) | 3.34350168 |
112 | macromolecular complex remodeling (GO:0034367) | 3.34350168 |
113 | positive regulation of cGMP biosynthetic process (GO:0030828) | 3.34334218 |
114 | tryptophan metabolic process (GO:0006568) | 3.33865363 |
115 | glycolipid catabolic process (GO:0019377) | 3.30662181 |
116 | aromatic amino acid family catabolic process (GO:0009074) | 3.30637572 |
117 | alditol metabolic process (GO:0019400) | 3.29304131 |
118 | positive regulation of lipid catabolic process (GO:0050996) | 3.29011884 |
119 | branched-chain amino acid metabolic process (GO:0009081) | 3.28096149 |
120 | vitamin biosynthetic process (GO:0009110) | 3.27613984 |
121 | plasma lipoprotein particle organization (GO:0071827) | 3.26114395 |
122 | glycosylceramide metabolic process (GO:0006677) | 3.25866509 |
123 | L-phenylalanine metabolic process (GO:0006558) | 3.25783023 |
124 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.25783023 |
125 | sodium-independent organic anion transport (GO:0043252) | 3.25475409 |
126 | response to nitric oxide (GO:0071731) | 3.25322380 |
127 | heme transport (GO:0015886) | 3.25292180 |
128 | sulfate transmembrane transport (GO:1902358) | 3.24128665 |
129 | mRNA modification (GO:0016556) | 3.23518326 |
130 | positive regulation of glycoprotein biosynthetic process (GO:0010560) | 3.23144822 |
131 | glycosphingolipid catabolic process (GO:0046479) | 3.22939638 |
132 | amino acid transmembrane transport (GO:0003333) | 3.22625543 |
133 | fatty acid oxidation (GO:0019395) | 3.22435625 |
134 | NADH metabolic process (GO:0006734) | 3.21036163 |
135 | sodium ion transport (GO:0006814) | 3.20778422 |
136 | sodium ion homeostasis (GO:0055078) | 3.20188951 |
137 | hormone catabolic process (GO:0042447) | 3.19046516 |
138 | drug metabolic process (GO:0017144) | 3.18214052 |
139 | metanephric epithelium development (GO:0072207) | 3.17027408 |
140 | lipid oxidation (GO:0034440) | 3.16133719 |
141 | sterol homeostasis (GO:0055092) | 3.15962474 |
142 | regulation of protein glycosylation (GO:0060049) | 3.15915357 |
143 | sulfate transport (GO:0008272) | 3.09332397 |
144 | L-ascorbic acid metabolic process (GO:0019852) | 3.09197777 |
145 | L-phenylalanine catabolic process (GO:0006559) | 3.08708711 |
146 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.08708711 |
147 | glycoside metabolic process (GO:0016137) | 3.08268121 |
148 | protein-lipid complex assembly (GO:0065005) | 3.08202222 |
149 | glutamine family amino acid biosynthetic process (GO:0009084) | 3.07762662 |
150 | omega-hydroxylase P450 pathway (GO:0097267) | 3.07317106 |
151 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.07146059 |
152 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.07146059 |
153 | negative regulation of cholesterol transport (GO:0032375) | 3.07018413 |
154 | negative regulation of sterol transport (GO:0032372) | 3.07018413 |
155 | protein-lipid complex subunit organization (GO:0071825) | 3.06811006 |
156 | cholesterol homeostasis (GO:0042632) | 3.06796795 |
157 | urea cycle (GO:0000050) | 3.06082154 |
158 | cellular response to vitamin D (GO:0071305) | 3.05507972 |
159 | nephron tubule development (GO:0072080) | 3.04727459 |
160 | glutathione derivative biosynthetic process (GO:1901687) | 3.04389472 |
161 | glutathione derivative metabolic process (GO:1901685) | 3.04389472 |
162 | cellular carbohydrate catabolic process (GO:0044275) | 3.03989214 |
163 | plasma lipoprotein particle assembly (GO:0034377) | 3.03215048 |
164 | response to growth hormone (GO:0060416) | 3.02817207 |
165 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 3.01812046 |
166 | digestive system process (GO:0022600) | 2.99775971 |
167 | glycerol metabolic process (GO:0006071) | 2.97341137 |
Rank | Gene Set | Z-score |
---|---|---|
1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 5.09871382 |
2 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 4.88691172 |
3 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.93265924 |
4 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 3.82672809 |
5 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.76726789 |
6 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 3.57863097 |
7 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 3.44879240 |
8 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.42842122 |
9 | AR_21909140_ChIP-Seq_LNCAP_Human | 3.22058014 |
10 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.06845084 |
11 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.89920873 |
12 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.68052306 |
13 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 2.52979883 |
14 | GATA4_25053715_ChIP-Seq_YYC3_Human | 2.48988317 |
15 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.45088393 |
16 | GATA6_25053715_ChIP-Seq_YYC3_Human | 2.39907962 |
17 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.39099187 |
18 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 2.30368898 |
19 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.29921886 |
20 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.24463411 |
21 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 2.23815340 |
22 | GATA1_22025678_ChIP-Seq_K562_Human | 2.23551780 |
23 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 2.15157545 |
24 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.10373906 |
25 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.00504797 |
26 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.97536461 |
27 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.91362292 |
28 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.87706093 |
29 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.86396929 |
30 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.80535176 |
31 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.78863625 |
32 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.75327069 |
33 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.73969698 |
34 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.72396642 |
35 | VDR_22108803_ChIP-Seq_LS180_Human | 1.71128124 |
36 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.69231335 |
37 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.67219571 |
38 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.66741915 |
39 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.66223306 |
40 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.66082765 |
41 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.57303573 |
42 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.55686994 |
43 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.51082394 |
44 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.50448560 |
45 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.47903443 |
46 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.47395736 |
47 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.46444471 |
48 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.45001147 |
49 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.43556150 |
50 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.42590315 |
51 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.40737031 |
52 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.39531677 |
53 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.34582366 |
54 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.33814948 |
55 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.33507540 |
56 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.33345592 |
57 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.31249962 |
58 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.30958835 |
59 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.27806893 |
60 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.26583758 |
61 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.25537946 |
62 | * PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.25437429 |
63 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.23462506 |
64 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.23401326 |
65 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.22097780 |
66 | ATF3_27146783_Chip-Seq_COLON_Human | 1.21707206 |
67 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.19287282 |
68 | P300_19829295_ChIP-Seq_ESCs_Human | 1.18733934 |
69 | * SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.18478149 |
70 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.18260130 |
71 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.18209947 |
72 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.17942738 |
73 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 1.14073984 |
74 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.12371068 |
75 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.11317104 |
76 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.09635530 |
77 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.07685058 |
78 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.07685058 |
79 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.07526395 |
80 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.07089796 |
81 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.06724179 |
82 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.06378141 |
83 | * PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.06350694 |
84 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.06178850 |
85 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.04484636 |
86 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 1.04122608 |
87 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.04117414 |
88 | * GATA2_19941826_ChIP-Seq_K562_Human | 1.03551625 |
89 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.03354456 |
90 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.02882948 |
91 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.02714485 |
92 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.02601072 |
93 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.02577959 |
94 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.02505367 |
95 | * SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.01559163 |
96 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.01547340 |
97 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.01378167 |
98 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.99249127 |
99 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.99211698 |
100 | * AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.98936663 |
101 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.98315560 |
102 | GATA1_19941826_ChIP-Seq_K562_Human | 0.98155139 |
103 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.97965171 |
104 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.97273252 |
105 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.97211814 |
106 | CJUN_26792858_Chip-Seq_BT549_Human | 0.97177326 |
107 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.97064880 |
108 | * STAT3_23295773_ChIP-Seq_U87_Human | 0.96439432 |
109 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.95430916 |
110 | * UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.94974425 |
111 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.94925876 |
112 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.94839030 |
113 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.94106777 |
114 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.92842422 |
115 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.92239885 |
116 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.92205881 |
117 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.92205528 |
118 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.92095235 |
119 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.91832294 |
120 | * SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.91351748 |
121 | * SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.91044449 |
122 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.90885909 |
123 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.90830933 |
124 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 0.90541010 |
125 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.90225134 |
126 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.89219290 |
127 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.88261524 |
128 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.88261524 |
129 | TCF4_23295773_ChIP-Seq_U87_Human | 0.88227843 |
130 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.88202163 |
131 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.87936909 |
132 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.87918197 |
133 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 0.87901121 |
134 | TP53_16413492_ChIP-PET_HCT116_Human | 0.87854976 |
135 | ETV1_20927104_ChIP-Seq_GIST48_Human | 0.87753648 |
136 | NANOG_18347094_ChIP-ChIP_MESCs_Mouse | 0.87727595 |
137 | SOX2_18692474_ChIP-Seq_MESCs_Mouse | 0.87584570 |
138 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.87489938 |
139 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.87489938 |
140 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.87363342 |
141 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.87164226 |
142 | * CBP_21632823_ChIP-Seq_H3396_Human | 0.87146567 |
143 | RXR_22108803_ChIP-Seq_LS180_Human | 0.86506868 |
144 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.86428540 |
145 | NANOG_18692474_ChIP-Seq_MEFs_Mouse | 0.85718610 |
146 | AR_25329375_ChIP-Seq_VCAP_Human | 0.85682473 |
147 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.85600257 |
148 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.85529571 |
149 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.85276730 |
150 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.85276730 |
151 | * CDX2_22108803_ChIP-Seq_LS180_Human | 0.84999500 |
152 | KLF5_25053715_ChIP-Seq_YYC3_Human | 0.83185714 |
153 | TCF3_18692474_ChIP-Seq_MESCs_Mouse | 0.82972209 |
154 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.81804081 |
155 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.79773094 |
156 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.78670274 |
157 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 0.78306384 |
158 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.78114328 |
159 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.77606343 |
160 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.76387807 |
161 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.76387807 |
162 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.75955242 |
163 | TCF3_18347094_ChIP-ChIP_MESCs_Mouse | 0.74383285 |
164 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.73936601 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0005360_urolithiasis | 9.61270817 |
2 | MP0004043_abnormal_pH_regulation | 4.64937549 |
3 | MP0005377_hearing/vestibular/ear_phenot | 4.27463674 |
4 | MP0003878_abnormal_ear_physiology | 4.27463674 |
5 | * MP0004019_abnormal_vitamin_homeostasis | 4.11519502 |
6 | MP0002139_abnormal_hepatobiliary_system | 3.96577054 |
7 | MP0005332_abnormal_amino_acid | 3.82078959 |
8 | * MP0009643_abnormal_urine_homeostasis | 3.23114732 |
9 | MP0002138_abnormal_hepatobiliary_system | 2.98397770 |
10 | MP0001765_abnormal_ion_homeostasis | 2.97966479 |
11 | MP0001666_abnormal_nutrient_absorption | 2.90372678 |
12 | MP0005365_abnormal_bile_salt | 2.75514726 |
13 | MP0003252_abnormal_bile_duct | 2.70563878 |
14 | MP0005085_abnormal_gallbladder_physiolo | 2.69383890 |
15 | MP0003195_calcinosis | 2.50916878 |
16 | MP0001958_emphysema | 2.47502347 |
17 | MP0008875_abnormal_xenobiotic_pharmacok | 2.44663861 |
18 | MP0010234_abnormal_vibrissa_follicle | 2.39745513 |
19 | MP0005636_abnormal_mineral_homeostasis | 2.38415322 |
20 | MP0001756_abnormal_urination | 2.37758569 |
21 | * MP0002136_abnormal_kidney_physiology | 2.33776418 |
22 | MP0009379_abnormal_foot_pigmentation | 2.19774686 |
23 | MP0005084_abnormal_gallbladder_morpholo | 2.15799386 |
24 | * MP0004264_abnormal_extraembryonic_tissu | 1.93176646 |
25 | MP0010155_abnormal_intestine_physiology | 1.83600038 |
26 | MP0000538_abnormal_urinary_bladder | 1.82430636 |
27 | MP0005409_darkened_coat_color | 1.74931807 |
28 | MP0003868_abnormal_feces_composition | 1.73005449 |
29 | MP0010329_abnormal_lipoprotein_level | 1.72587565 |
30 | MP0004147_increased_porphyrin_level | 1.67335763 |
31 | MP0005058_abnormal_lysosome_morphology | 1.62419785 |
32 | MP0003300_gastrointestinal_ulcer | 1.53995742 |
33 | MP0004272_abnormal_basement_membrane | 1.51297255 |
34 | MP0003718_maternal_effect | 1.50510259 |
35 | MP0009840_abnormal_foam_cell | 1.45649302 |
36 | MP0003191_abnormal_cellular_cholesterol | 1.42110288 |
37 | MP0003879_abnormal_hair_cell | 1.36783522 |
38 | MP0001501_abnormal_sleep_pattern | 1.30214939 |
39 | MP0003283_abnormal_digestive_organ | 1.23794824 |
40 | MP0008961_abnormal_basal_metabolism | 1.22359552 |
41 | MP0005451_abnormal_body_composition | 1.16472767 |
42 | MP0002876_abnormal_thyroid_physiology | 1.16426569 |
43 | MP0003705_abnormal_hypodermis_morpholog | 1.16339296 |
44 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.14705772 |
45 | MP0004885_abnormal_endolymph | 1.12641418 |
46 | MP0002796_impaired_skin_barrier | 1.10380186 |
47 | MP0002089_abnormal_postnatal_growth/wei | 1.08595738 |
48 | MP0006054_spinal_hemorrhage | 1.08393836 |
49 | MP0005448_abnormal_energy_balance | 1.05036384 |
50 | MP0001188_hyperpigmentation | 1.03367700 |
51 | MP0003941_abnormal_skin_development | 1.03056893 |
52 | MP0000537_abnormal_urethra_morphology | 1.00971519 |
53 | MP0003806_abnormal_nucleotide_metabolis | 0.97215966 |
54 | MP0000678_abnormal_parathyroid_gland | 0.96250950 |
55 | MP0005319_abnormal_enzyme/_coenzyme | 0.93743176 |
56 | MP0002896_abnormal_bone_mineralization | 0.93194378 |
57 | MP0009115_abnormal_fat_cell | 0.89526692 |
58 | MP0008872_abnormal_physiological_respon | 0.88176037 |
59 | MP0000490_abnormal_crypts_of | 0.87936489 |
60 | MP0002118_abnormal_lipid_homeostasis | 0.87278263 |
61 | MP0005174_abnormal_tail_pigmentation | 0.86626193 |
62 | * MP0002135_abnormal_kidney_morphology | 0.86216341 |
63 | MP0003638_abnormal_response/metabolism_ | 0.86120807 |
64 | MP0002098_abnormal_vibrissa_morphology | 0.86039619 |
65 | MP0001764_abnormal_homeostasis | 0.83568803 |
66 | MP0003183_abnormal_peptide_metabolism | 0.82256816 |
67 | MP0002971_abnormal_brown_adipose | 0.82057610 |
68 | MP0005501_abnormal_skin_physiology | 0.81647556 |
69 | MP0005410_abnormal_fertilization | 0.81571762 |
70 | MP0005666_abnormal_adipose_tissue | 0.80948423 |
71 | MP0001986_abnormal_taste_sensitivity | 0.80931558 |
72 | MP0004270_analgesia | 0.77319813 |
73 | MP0005166_decreased_susceptibility_to | 0.76287530 |
74 | MP0002928_abnormal_bile_duct | 0.75656767 |
75 | MP0002396_abnormal_hematopoietic_system | 0.75382003 |
76 | MP0000609_abnormal_liver_physiology | 0.74809840 |
77 | MP0000230_abnormal_systemic_arterial | 0.74640306 |
78 | MP0002822_catalepsy | 0.74416195 |
79 | MP0002168_other_aberrant_phenotype | 0.74318424 |
80 | MP0005167_abnormal_blood-brain_barrier | 0.72235986 |
81 | MP0003123_paternal_imprinting | 0.67272575 |
82 | MP0003186_abnormal_redox_activity | 0.66371608 |
83 | MP0001873_stomach_inflammation | 0.65339982 |
84 | MP0000015_abnormal_ear_pigmentation | 0.64836109 |
85 | MP0000462_abnormal_digestive_system | 0.64513836 |
86 | MP0009642_abnormal_blood_homeostasis | 0.62696136 |
87 | MP0001293_anophthalmia | 0.61954186 |
88 | MP0008469_abnormal_protein_level | 0.61446654 |
89 | MP0005408_hypopigmentation | 0.61395544 |
90 | MP0003953_abnormal_hormone_level | 0.60330378 |
91 | MP0000249_abnormal_blood_vessel | 0.60255805 |
92 | MP0000477_abnormal_intestine_morphology | 0.59741684 |
93 | MP0009384_cardiac_valve_regurgitation | 0.59070057 |
94 | MP0010678_abnormal_skin_adnexa | 0.58749344 |
95 | MP0002638_abnormal_pupillary_reflex | 0.57010956 |
96 | MP0001845_abnormal_inflammatory_respons | 0.56486185 |
97 | MP0009053_abnormal_anal_canal | 0.56061741 |
98 | MP0000516_abnormal_urinary_system | 0.55386893 |
99 | MP0005367_renal/urinary_system_phenotyp | 0.55386893 |
100 | MP0000371_diluted_coat_color | 0.55303619 |
101 | MP0004858_abnormal_nervous_system | 0.54304171 |
102 | MP0004484_altered_response_of | 0.53974075 |
103 | MP0002069_abnormal_eating/drinking_beha | 0.53913341 |
104 | MP0005395_other_phenotype | 0.53516183 |
105 | MP0006036_abnormal_mitochondrial_physio | 0.50373620 |
106 | MP0006138_congestive_heart_failure | 0.50120753 |
107 | MP0003866_abnormal_defecation | 0.49881546 |
108 | MP0003566_abnormal_cell_adhesion | 0.49530990 |
109 | MP0005535_abnormal_body_temperature | 0.49141183 |
110 | MP0000427_abnormal_hair_cycle | 0.48220764 |
111 | MP0003045_fibrosis | 0.48126753 |
112 | MP0000598_abnormal_liver_morphology | 0.47783814 |
113 | MP0009672_abnormal_birth_weight | 0.47598808 |
114 | MP0000604_amyloidosis | 0.47437382 |
115 | MP0003315_abnormal_perineum_morphology | 0.45717082 |
116 | MP0005334_abnormal_fat_pad | 0.44581432 |
117 | MP0001485_abnormal_pinna_reflex | 0.44113930 |
118 | MP0001177_atelectasis | 0.43294619 |
119 | MP0001849_ear_inflammation | 0.42652409 |
120 | MP0003329_amyloid_beta_deposits | 0.42065524 |
121 | MP0001664_abnormal_digestion | 0.41417508 |
122 | MP0010352_gastrointestinal_tract_polyps | 0.41352404 |
123 | MP0001663_abnormal_digestive_system | 0.39911687 |
124 | MP0000465_gastrointestinal_hemorrhage | 0.39467208 |
125 | MP0005381_digestive/alimentary_phenotyp | 0.38633000 |
126 | MP0008004_abnormal_stomach_pH | 0.38597859 |
127 | MP0002078_abnormal_glucose_homeostasis | 0.37901461 |
128 | MP0003724_increased_susceptibility_to | 0.37453121 |
129 | * MP0002086_abnormal_extraembryonic_tissu | 0.37393371 |
130 | MP0005670_abnormal_white_adipose | 0.36863995 |
131 | MP0009764_decreased_sensitivity_to | 0.36588652 |
132 | MP0001661_extended_life_span | 0.36307568 |
133 | MP0003172_abnormal_lysosome_physiology | 0.35935939 |
134 | MP0002697_abnormal_eye_size | 0.35847827 |
135 | MP0000534_abnormal_ureter_morphology | 0.35795390 |
136 | MP0000377_abnormal_hair_follicle | 0.35551319 |
137 | MP0005220_abnormal_exocrine_pancreas | 0.35209648 |
138 | MP0005376_homeostasis/metabolism_phenot | 0.34616056 |
139 | MP0002998_abnormal_bone_remodeling | 0.33717832 |
140 | MP0001730_embryonic_growth_arrest | 0.33127200 |
141 | MP0003795_abnormal_bone_structure | 0.32488131 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Increased circulating renin level (HP:0000848) | 7.11900245 |
2 | Metabolic alkalosis (HP:0200114) | 6.40359577 |
3 | Hypokalemic alkalosis (HP:0001949) | 6.33165614 |
4 | Hyperactive renin-angiotensin system (HP:0000841) | 6.24502180 |
5 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 6.18246029 |
6 | Hypomagnesemia (HP:0002917) | 6.16326143 |
7 | Proximal tubulopathy (HP:0000114) | 5.88147471 |
8 | Gout (HP:0001997) | 5.82875271 |
9 | Abnormal urine output (HP:0012590) | 5.61708062 |
10 | Polyuria (HP:0000103) | 5.58815575 |
11 | Abnormality of chloride homeostasis (HP:0011422) | 5.53680915 |
12 | Abnormality of magnesium homeostasis (HP:0004921) | 5.37776474 |
13 | Abnormality of renal excretion (HP:0011036) | 5.30045646 |
14 | Hyperglycinuria (HP:0003108) | 5.08977689 |
15 | Chronic diarrhea (HP:0002028) | 4.55759642 |
16 | Abnormal drinking behavior (HP:0030082) | 4.46861578 |
17 | Polydipsia (HP:0001959) | 4.46861578 |
18 | Tetany (HP:0001281) | 4.45708249 |
19 | Pigmentary retinal degeneration (HP:0001146) | 4.32419103 |
20 | Hyperuricemia (HP:0002149) | 4.31741491 |
21 | Increased purine levels (HP:0004368) | 4.31741491 |
22 | Abnormality of purine metabolism (HP:0004352) | 4.20245994 |
23 | Abnormality of renin-angiotensin system (HP:0000847) | 4.16547015 |
24 | Abnormality of glycine metabolism (HP:0010895) | 4.15717782 |
25 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.15717782 |
26 | Hypercalciuria (HP:0002150) | 4.02935632 |
27 | Alkalosis (HP:0001948) | 4.02414498 |
28 | Hyperaldosteronism (HP:0000859) | 3.99930735 |
29 | Renal salt wasting (HP:0000127) | 3.99737236 |
30 | Hydroxyprolinuria (HP:0003080) | 3.98384738 |
31 | Abnormality of proline metabolism (HP:0010907) | 3.98384738 |
32 | Glycosuria (HP:0003076) | 3.66477132 |
33 | Abnormality of urine glucose concentration (HP:0011016) | 3.66477132 |
34 | Hyperphosphaturia (HP:0003109) | 3.49168443 |
35 | Malnutrition (HP:0004395) | 3.45112520 |
36 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.40247954 |
37 | Delayed epiphyseal ossification (HP:0002663) | 3.35492899 |
38 | Hypokalemia (HP:0002900) | 3.33759756 |
39 | Generalized aminoaciduria (HP:0002909) | 3.33370766 |
40 | Abnormal urine phosphate concentration (HP:0012599) | 3.27565061 |
41 | Hypolipoproteinemia (HP:0010981) | 3.22085541 |
42 | Nephrolithiasis (HP:0000787) | 3.21283049 |
43 | Decreased circulating renin level (HP:0003351) | 3.21274054 |
44 | Widely patent fontanelles and sutures (HP:0004492) | 3.19699437 |
45 | Abnormality of nucleobase metabolism (HP:0010932) | 3.17281261 |
46 | * Confusion (HP:0001289) | 3.01535180 |
47 | Potter facies (HP:0002009) | 2.99397239 |
48 | Facial shape deformation (HP:0011334) | 2.99397239 |
49 | Nausea (HP:0002018) | 2.99380484 |
50 | Renal tubular acidosis (HP:0001947) | 2.99161620 |
51 | Steatorrhea (HP:0002570) | 2.91483710 |
52 | Ketoacidosis (HP:0001993) | 2.90863552 |
53 | Thin bony cortex (HP:0002753) | 2.89504405 |
54 | Congenital sensorineural hearing impairment (HP:0008527) | 2.79269959 |
55 | Focal segmental glomerulosclerosis (HP:0000097) | 2.77265605 |
56 | Hypoglycemic coma (HP:0001325) | 2.74881710 |
57 | Hypophosphatemia (HP:0002148) | 2.74716307 |
58 | Hyperglycinemia (HP:0002154) | 2.73460824 |
59 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.69742751 |
60 | Abnormality of potassium homeostasis (HP:0011042) | 2.69553456 |
61 | Dehydration (HP:0001944) | 2.68557881 |
62 | Nephrocalcinosis (HP:0000121) | 2.61405863 |
63 | Metaphyseal cupping (HP:0003021) | 2.53157003 |
64 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.48711190 |
65 | Ileus (HP:0002595) | 2.48259356 |
66 | Rickets (HP:0002748) | 2.44628043 |
67 | Bicornuate uterus (HP:0000813) | 2.41681693 |
68 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.40399261 |
69 | Ketosis (HP:0001946) | 2.39031348 |
70 | Hypophosphatemic rickets (HP:0004912) | 2.38716168 |
71 | Vascular calcification (HP:0004934) | 2.37895851 |
72 | * Abnormality of vitamin metabolism (HP:0100508) | 2.36458446 |
73 | Posterior subcapsular cataract (HP:0007787) | 2.36182595 |
74 | Enlarged kidneys (HP:0000105) | 2.31816522 |
75 | Hyperammonemia (HP:0001987) | 2.23316527 |
76 | Xanthomatosis (HP:0000991) | 2.22709577 |
77 | Adrenal overactivity (HP:0002717) | 2.18584764 |
78 | Abdominal distention (HP:0003270) | 2.17510812 |
79 | High anterior hairline (HP:0009890) | 2.17320312 |
80 | Chorioretinal atrophy (HP:0000533) | 2.15966426 |
81 | Hypoglycemic seizures (HP:0002173) | 2.14322036 |
82 | Cardiovascular calcification (HP:0011915) | 2.14086707 |
83 | Symptomatic seizures (HP:0011145) | 2.13691227 |
84 | Vacuolated lymphocytes (HP:0001922) | 2.12492968 |
85 | * Abnormality of the vitamin B12 metabolism (HP:0004341) | 2.12443048 |
86 | Tubulointerstitial fibrosis (HP:0005576) | 2.11685380 |
87 | Hypobetalipoproteinemia (HP:0003563) | 2.11428154 |
88 | Epidermoid cyst (HP:0200040) | 2.09563099 |
89 | Abnormal glucose tolerance (HP:0001952) | 2.05841737 |
90 | Abnormality of sodium homeostasis (HP:0010931) | 2.04911468 |
91 | Wide cranial sutures (HP:0010537) | 2.03926267 |
92 | Hyponatremia (HP:0002902) | 2.03590657 |
93 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.01943131 |
94 | Subcapsular cataract (HP:0000523) | 2.01168814 |
95 | Bilateral sensorineural hearing impairment (HP:0008619) | 2.00711335 |
96 | Chondrocalcinosis (HP:0000934) | 2.00662713 |
97 | Abnormality of the costochondral junction (HP:0000919) | 2.00037021 |
98 | Tubular atrophy (HP:0000092) | 1.99966805 |
99 | Delayed CNS myelination (HP:0002188) | 1.99606379 |
100 | * Abnormality of vitamin B metabolism (HP:0004340) | 1.99465626 |
101 | Partial agenesis of the corpus callosum (HP:0001338) | 1.98133021 |
102 | Glomerulosclerosis (HP:0000096) | 1.94812076 |
103 | Metabolic acidosis (HP:0001942) | 1.94348582 |
104 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.93882684 |
105 | Hypotension (HP:0002615) | 1.92509661 |
106 | Poikilocytosis (HP:0004447) | 1.91476697 |
107 | Intrahepatic cholestasis (HP:0001406) | 1.91021699 |
108 | Fat malabsorption (HP:0002630) | 1.90937229 |
109 | Hypoplasia of the iris (HP:0007676) | 1.90013428 |
110 | Hypoalbuminemia (HP:0003073) | 1.89685608 |
111 | Abnormal albumin level (HP:0012116) | 1.89685608 |
112 | Acanthocytosis (HP:0001927) | 1.89289645 |
113 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.88941859 |
114 | Abnormal tarsal ossification (HP:0008369) | 1.87462345 |
115 | Enlarged epiphyses (HP:0010580) | 1.86274689 |
116 | Abnormality of Sharpey fibers (HP:0100685) | 1.85694580 |
117 | Renal tubular dysfunction (HP:0000124) | 1.84659632 |
118 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.84597291 |
119 | Dicarboxylic aciduria (HP:0003215) | 1.84597291 |
120 | Osteomalacia (HP:0002749) | 1.80535563 |
121 | Exercise-induced muscle cramps (HP:0003710) | 1.79770961 |
122 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.75987011 |
123 | Vomiting (HP:0002013) | 1.75161459 |
124 | Hypothermia (HP:0002045) | 1.71892747 |
125 | White forelock (HP:0002211) | 1.70429349 |
126 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 1.68751387 |
Rank | Gene Set | Z-score |
---|---|---|
1 | WNK4 | 7.07615392 |
2 | WNK3 | 7.04062101 |
3 | OXSR1 | 6.26611060 |
4 | MST4 | 4.26110057 |
5 | STK39 | 3.44610369 |
6 | SCYL2 | 2.68987001 |
7 | STK38L | 2.43672415 |
8 | MST1R | 2.26669327 |
9 | FRK | 2.19453548 |
10 | NEK1 | 2.17718991 |
11 | GRK6 | 2.16792373 |
12 | STK10 | 1.86611172 |
13 | TNIK | 1.73004539 |
14 | LRRK2 | 1.69988768 |
15 | PIK3CG | 1.57518413 |
16 | PDK3 | 1.46904447 |
17 | PDK4 | 1.46904447 |
18 | NLK | 1.41051699 |
19 | BCKDK | 1.40760665 |
20 | PTK6 | 1.37913083 |
21 | MET | 1.37700882 |
22 | EPHA2 | 1.35167467 |
23 | WNK1 | 1.34493133 |
24 | RIPK1 | 1.32527160 |
25 | EPHA4 | 1.30412876 |
26 | MAP3K2 | 1.29755540 |
27 | LATS1 | 1.18135960 |
28 | SGK494 | 1.17591612 |
29 | SGK223 | 1.17591612 |
30 | PTK2 | 1.15072955 |
31 | MAP3K3 | 1.10926002 |
32 | PRKCI | 1.08568157 |
33 | PDK2 | 1.07325209 |
34 | CASK | 1.07292548 |
35 | STK38 | 1.07272962 |
36 | LMTK2 | 1.05269403 |
37 | TYK2 | 1.03635014 |
38 | MAP3K10 | 1.02307422 |
39 | PAK4 | 0.99435050 |
40 | TESK2 | 0.97571153 |
41 | NME1 | 0.95594281 |
42 | EPHA3 | 0.94809010 |
43 | GRK1 | 0.92666715 |
44 | MAP3K8 | 0.90933786 |
45 | FER | 0.90060094 |
46 | FGFR4 | 0.83331368 |
47 | PRKG2 | 0.82151238 |
48 | TEC | 0.80580170 |
49 | TAOK3 | 0.79600451 |
50 | FGFR3 | 0.79361819 |
51 | TXK | 0.79197540 |
52 | EPHB1 | 0.78766789 |
53 | SGK3 | 0.78126936 |
54 | AKT3 | 0.78067093 |
55 | PAK3 | 0.77138100 |
56 | MAP4K1 | 0.76002017 |
57 | EPHB2 | 0.75999405 |
58 | AKT2 | 0.73552419 |
59 | TTK | 0.70953355 |
60 | MAP3K12 | 0.70341488 |
61 | ADRBK2 | 0.66396036 |
62 | GSK3A | 0.63837108 |
63 | NUAK1 | 0.63155768 |
64 | MAP3K7 | 0.62273814 |
65 | PIK3CA | 0.61543900 |
66 | MAP2K2 | 0.60543893 |
67 | BMPR1B | 0.58205251 |
68 | PRKAA1 | 0.57036104 |
69 | DAPK2 | 0.56423432 |
70 | PINK1 | 0.55944298 |
71 | NEK6 | 0.55636724 |
72 | MAP2K6 | 0.54135841 |
73 | SGK2 | 0.53944344 |
74 | PDPK1 | 0.53029783 |
75 | MAPK11 | 0.52581224 |
76 | BTK | 0.52443870 |
77 | PIM1 | 0.50218534 |
78 | PRKAA2 | 0.50194479 |
79 | SGK1 | 0.48851163 |
80 | IRAK1 | 0.48181775 |
81 | ERN1 | 0.47283717 |
82 | PDGFRA | 0.46676976 |
83 | MYLK | 0.46446722 |
84 | TRIB3 | 0.46185404 |
85 | PKN2 | 0.40892062 |
86 | STK3 | 0.40858313 |
87 | BMX | 0.40742994 |
88 | DDR2 | 0.40161310 |
89 | JAK1 | 0.39872937 |
90 | CAMKK2 | 0.39715074 |
91 | CDK19 | 0.38948797 |
92 | INSRR | 0.36996561 |
93 | KIT | 0.36608267 |
94 | MAP3K1 | 0.35505324 |
95 | TLK1 | 0.34886959 |
96 | KSR2 | 0.34344081 |
97 | PDK1 | 0.34144890 |
98 | TIE1 | 0.33948550 |
99 | STK11 | 0.33911177 |
100 | CSK | 0.33442504 |
101 | ERBB2 | 0.32118827 |
102 | ITK | 0.31245823 |
103 | KSR1 | 0.31082849 |
104 | ROCK1 | 0.30549011 |
105 | MUSK | 0.30223484 |
106 | FGFR2 | 0.30197628 |
107 | PRKCE | 0.30125436 |
108 | DYRK1B | 0.29000636 |
109 | PRKACA | 0.28581723 |
110 | RET | 0.27824828 |
111 | MAP4K2 | 0.27340886 |
112 | TGFBR2 | 0.27204797 |
113 | MAPK7 | 0.26249892 |
114 | YES1 | 0.24995085 |
115 | IGF1R | 0.24838909 |
116 | SYK | 0.24640380 |
117 | PDGFRB | 0.24631676 |
118 | LCK | 0.24414485 |
119 | FYN | 0.23589372 |
120 | CSNK1A1 | 0.23572779 |
121 | MAP3K11 | 0.22808439 |
122 | MELK | 0.22640762 |
123 | MAP2K1 | 0.21934680 |
124 | MTOR | 0.21865850 |
125 | FGFR1 | 0.19639956 |
126 | CDK12 | 0.19257060 |
127 | ZAK | 0.19094364 |
128 | ERBB4 | 0.18783663 |
129 | INSR | 0.18599742 |
130 | PRKCD | 0.18375697 |
131 | SRC | 0.16436603 |
132 | MATK | 0.15696939 |
133 | NTRK1 | 0.15438022 |
134 | PRKCA | 0.14758879 |
135 | TGFBR1 | 0.14040614 |
136 | PRKACG | 0.12460983 |
137 | ROCK2 | 0.12429522 |
138 | PRKCQ | 0.12345299 |
139 | ACVR1B | 0.08832521 |
140 | PRKCZ | 0.08409836 |
141 | TAOK1 | 0.07988160 |
142 | LATS2 | 0.06205500 |
143 | AURKB | 0.06036929 |
144 | NEK2 | 0.05834011 |
145 | ABL2 | 0.05284250 |
146 | PTK2B | 0.04472270 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 3.46205136 |
2 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 3.31312866 |
3 | * Vitamin digestion and absorption_Homo sapiens_hsa04977 | 3.06835198 |
4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.83371298 |
5 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.78109128 |
6 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.70643689 |
7 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.64996646 |
8 | Renin-angiotensin system_Homo sapiens_hsa04614 | 2.57722440 |
9 | Mineral absorption_Homo sapiens_hsa04978 | 2.48568414 |
10 | Fat digestion and absorption_Homo sapiens_hsa04975 | 2.38785522 |
11 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.32843317 |
12 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.29875978 |
13 | Bile secretion_Homo sapiens_hsa04976 | 2.25008819 |
14 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 2.19459647 |
15 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.15729772 |
16 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.15265226 |
17 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.14458868 |
18 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.14263402 |
19 | Protein digestion and absorption_Homo sapiens_hsa04974 | 2.11647402 |
20 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.06913313 |
21 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.03580481 |
22 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.01709108 |
23 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.96622950 |
24 | Peroxisome_Homo sapiens_hsa04146 | 1.83883157 |
25 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.81027526 |
26 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.76158633 |
27 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.67855941 |
28 | Carbon metabolism_Homo sapiens_hsa01200 | 1.63097058 |
29 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.62902681 |
30 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.59457663 |
31 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.54984773 |
32 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.54439519 |
33 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.53889395 |
34 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.53143022 |
35 | Histidine metabolism_Homo sapiens_hsa00340 | 1.52654693 |
36 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.51120799 |
37 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.49411808 |
38 | Lysine degradation_Homo sapiens_hsa00310 | 1.44810125 |
39 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.41277756 |
40 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.38477894 |
41 | Galactose metabolism_Homo sapiens_hsa00052 | 1.37723157 |
42 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.34761387 |
43 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.31095149 |
44 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.30794933 |
45 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.26446943 |
46 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.24300682 |
47 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.23599009 |
48 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.21313113 |
49 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.17164298 |
50 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.13177932 |
51 | Other glycan degradation_Homo sapiens_hsa00511 | 1.12361977 |
52 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.10665281 |
53 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.02292882 |
54 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.99186523 |
55 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.95418178 |
56 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.92261350 |
57 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.89497814 |
58 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.87756575 |
59 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.85462649 |
60 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.76316784 |
61 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.70718819 |
62 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.57051024 |
63 | ABC transporters_Homo sapiens_hsa02010 | 0.56672503 |
64 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.56555991 |
65 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.56153373 |
66 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.53752822 |
67 | Tight junction_Homo sapiens_hsa04530 | 0.53687817 |
68 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.51897499 |
69 | Lysosome_Homo sapiens_hsa04142 | 0.50003700 |
70 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.48326977 |
71 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.46840219 |
72 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.46728018 |
73 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.46628703 |
74 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.45354068 |
75 | Metabolic pathways_Homo sapiens_hsa01100 | 0.40455543 |
76 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.40401574 |
77 | Renin secretion_Homo sapiens_hsa04924 | 0.40384771 |
78 | Asthma_Homo sapiens_hsa05310 | 0.38589739 |
79 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.37443047 |
80 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.35810647 |
81 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.34571152 |
82 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.33965237 |
83 | Allograft rejection_Homo sapiens_hsa05330 | 0.33278675 |
84 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.32484347 |
85 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.31805343 |
86 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.30187904 |
87 | Cocaine addiction_Homo sapiens_hsa05030 | 0.30107971 |
88 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.28792464 |
89 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.28480765 |
90 | Alcoholism_Homo sapiens_hsa05034 | 0.26298693 |
91 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.25680135 |
92 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.24437451 |
93 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.23921817 |
94 | Insulin resistance_Homo sapiens_hsa04931 | 0.23214750 |
95 | Retinol metabolism_Homo sapiens_hsa00830 | 0.22315736 |
96 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.22007948 |
97 | Bladder cancer_Homo sapiens_hsa05219 | 0.21893622 |
98 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.21183477 |
99 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.20583854 |
100 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.19607430 |
101 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.18805594 |
102 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.16929170 |
103 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.16779490 |
104 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.15618278 |
105 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.15381487 |
106 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.13640012 |
107 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.11003448 |
108 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.09949003 |
109 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.09451553 |
110 | Insulin secretion_Homo sapiens_hsa04911 | 0.09366291 |
111 | Adherens junction_Homo sapiens_hsa04520 | 0.08950611 |
112 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.08763100 |
113 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.08413989 |
114 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.08238256 |
115 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.07995851 |
116 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.07555877 |
117 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.07049003 |
118 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.06331041 |
119 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.05923840 |
120 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.05610397 |
121 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.05501661 |
122 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.04196899 |
123 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.02758278 |
124 | Hepatitis C_Homo sapiens_hsa05160 | 0.02256444 |
125 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.01940519 |
126 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.01561898 |
127 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.00925272 |